etoposide has been researched along with 4,5,6,7-tetrabromo-2-azabenzimidazole in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Penzo, D; Pinna, LA; Ruzzene, M | 1 |
1 other study(ies) available for etoposide and 4,5,6,7-tetrabromo-2-azabenzimidazole
Article | Year |
---|---|
Protein kinase CK2 inhibitor 4,5,6,7-tetrabromobenzotriazole (TBB) induces apoptosis and caspase-dependent degradation of haematopoietic lineage cell-specific protein 1 (HS1) in Jurkat cells.
Topics: Adaptor Proteins, Signal Transducing; Apoptosis; Blood Proteins; Casein Kinase II; Caspase 3; Caspases; Cell Death; Cell Survival; Cytochrome c Group; DNA Fragmentation; Dose-Response Relationship, Drug; Enzyme Inhibitors; Etoposide; Humans; Jurkat Cells; Phosphorylation; Poly(ADP-ribose) Polymerases; Precipitin Tests; Protein Binding; Protein Serine-Threonine Kinases; Serine; Threonine; Time Factors; Triazoles; Tyrosine | 2002 |